Lore Decoster

6PUBLICATIONS
16CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 06, 2026
Afatinib for Advanced Cancers Carrying an EGFR, HER2, or HER3 Mutation: An Open-Label, Phase II, Belgian Precision Study.

|May 27, 2021
Targeted Therapies in Older Adults With Solid Tumors.

Nicolò Matteo Luca Battisti, Lore Decoster, Grant R Williams

|Mar 12, 2021
Real-World Treatment Patterns, Epidermal Growth Factor Receptor (EGFR) Testing and Outcomes in EGFR-Mutated Advanced Non-small Cell Lung Cancer Patients in Belgium: Results from the REVEAL Study.

Kristof Cuppens, Liesbet Lodewyckx, Ingel Demedts

|May 11, 2019
Retrospective comparison of two consecutive cohorts of adjuvant chemotherapy regimens of cyclophosphamide with either docetaxel or paclitaxel in older patients with early breast cancer.

Sofie Joris, Christel Fontaine, Lore Decoster

|Dec 30, 2017
Docetaxel/cyclophosphamide chemotherapy in older patients with breast cancer.

Lore Decoster, Christel Fontaine, Leen Vanacker

|Jun 22, 2017
Geriatric Assessment and Functional Decline in Older Patients with Lung Cancer.

L Decoster, C Kenis, D Schallier

Pageof 1

Frequent Collaborators

1 joint publications

Sofie Joris

1 joint publications

Kristof Cuppens

1 joint publications

Liesbet Lodewyckx

1 joint publications

Ingel Demedts